Submit Deal

JAZZ PHARMACEUTICALS

HQ - Dublin

Summary

Jazz Pharmaceuticals is a specialty biopharmaceutical company that focuses on developing, manufacturing, and commercializing innovative drugs to address unmet medical needs

Deals Overview

Total Deals6

Valued Deals5

Total Value£ 6.32 B

Avg. Deal Size£ 1.26 B

Market Context

Senior Management

Bruce Cozadd
Chairman and CEO
Renee Gala
CFO
Jacqueline Kirby
Vice President, Corporate Affairs & Government Relations

Sort

25 May 2016|France|Biotechnology

Target: ALIZE PHARMA SAS

Bidder: JAZZ PHARMACEUTICALS

1 Service Providers

1 Bidder

4 Dealmakers

4 Bidder

£ 13 M

Value

10 Jul 2019|United Kingdom|Medical Equipment

Target: REDX PHARMA'S PAN-RAF INHIBITOR PROGRAM

Bidder: JAZZ PHARMACEUTICALS

2 Service Providers

1 Bidder | 1 Vendor

2 Dealmakers

1 Bidder | 1 Vendor

n/a

Value

12 Aug 2019|United States|Biotechnology

Target: CAVION INC

Bidder: JAZZ PHARMACEUTICALS

6 Service Providers

4 Target | 2 Bidder

5 Dealmakers

1 Target | 4 Bidder

£ 260 M

Value

03 Feb 2021|United Kingdom|Pharmaceuticals

Target: GW PHARMACEUTICALS PLC

Bidder: JAZZ PHARMACEUTICALS

20 Service Providers

7 Target | 13 Bidder

85 Dealmakers

33 Target | 52 Bidder

£ 5.27 B

Value

28 Mar 2022|United States|Biotechnology

Target: SUNOSI

Bidder: AXSOME THERAPEUTICS

8 Service Providers

4 Bidder | 4 Vendor

42 Dealmakers

21 Bidder | 22 Vendor

£ 40 M

Value

05 Mar 2025|United States|Pharmaceuticals

Target: CHIMERIX

Bidder: JAZZ PHARMACEUTICALS

10 Service Providers

6 Target | 4 Bidder

53 Dealmakers

31 Target | 22 Bidder

£ 734 M

Value